Ameritas Investment Partners, Inc. - JOUNCE THERAPEUTICS INC ownership

JOUNCE THERAPEUTICS INC's ticker is JNCE and the CUSIP is 481116101. A total of 106 filers reported holding JOUNCE THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.23 and the average weighting 0.5%.

Quarter-by-quarter ownership
Ameritas Investment Partners, Inc. ownership history of JOUNCE THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$4,782
+63.7%
2,5850.0%0.00%
Q4 2022$2,921
-51.3%
2,5850.0%0.00%
Q3 2022$6,000
-14.3%
2,5850.0%0.00%
Q2 2022$7,000
-61.1%
2,5850.0%0.00%
-100.0%
Q1 2022$18,000
-18.2%
2,5850.0%0.00%0.0%
Q4 2021$22,000
+15.8%
2,5850.0%0.00%0.0%
Q3 2021$19,000
+5.6%
2,5850.0%0.00%0.0%
Q2 2021$18,000
+38.5%
2,585
+109.7%
0.00%
Q1 2021$13,000
+44.4%
1,2330.0%0.00%
Q4 2020$9,000
-10.0%
1,2330.0%0.00%
Q3 2020$10,000
+11.1%
1,2330.0%0.00%
Q2 2020$9,000
+50.0%
1,2330.0%0.00%
Q1 2020$6,000
-45.5%
1,2330.0%0.00%
Q4 2019$11,000
+175.0%
1,2330.0%0.00%
Q3 2019$4,000
-33.3%
1,2330.0%0.00%
Q2 2019$6,000
-25.0%
1,2330.0%0.00%
Q1 2019$8,000
+100.0%
1,2330.0%0.00%
Q4 2018$4,000
-50.0%
1,2330.0%0.00%
Q3 2018$8,000
-11.1%
1,2330.0%0.00%
Q2 2018$9,000
-67.9%
1,2330.0%0.00%
-100.0%
Q1 2018$28,000
+75.0%
1,2330.0%0.00%0.0%
Q4 2017$16,000
+60.0%
1,233
+98.9%
0.00%
Q3 2017$10,000
+11.1%
6200.0%0.00%
Q2 2017$9,000
-35.7%
6200.0%0.00%
-100.0%
Q1 2017$14,0006200.00%
Other shareholders
JOUNCE THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
TRV GP II, LLC 572,829$1,340,000100.00%
TRV GP III, LLC 1,148,780$2,688,0001.17%
COWEN AND COMPANY, LLC 3,647,430$8,535,0000.82%
Octagon Capital Advisors LP 1,400,000$3,276,0000.56%
Deep Track Capital, LP 4,259,653$9,968,0000.46%
PFM Health Sciences, LP 4,094,488$9,581,0000.35%
RTW INVESTMENTS, LP 5,106,341$11,949,0000.28%
Omega Fund Management, LLC 275,513$645,0000.24%
Monarch Partners Asset Management LLC 228,370$534,0000.16%
Orbimed Advisors 2,928,900$6,854,0000.13%
View complete list of JOUNCE THERAPEUTICS INC shareholders